Suchergebnisse - "Biswas, Largee"

PubPharm (9)

1

Leveraging selective knockdown of Sost gene by polyethyleneimine-siRNA-chitosan reduced gold nanoparticles to promote osteogenesis in MC3T3-E1 & MEF cells

enthalten in: Nanomedicine (London, England) | 2024

von Niveria, K. | ZafarYab, M. | Biswas, L. | +2

2

Neuroprotective potential of erucic acid via inhibition of N2a cell lines and rotenone induced Parkinson's disease rat model

enthalten in: Indian journal of pharmacology | 2023

von Sharma, B. | Gupta, P. | Biswas, L. | +4

3

Nanoparticles for combined photo- and chemo-dynamic therapy of cancer cells involving endogenous glutathione depletion

enthalten in: Nanomedicine (London, England) | 2023

von Mittal, A. | Yadav, M. | Biswas, L. | +2

4

Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro, and in vivo studies

enthalten in: Journal of drug targeting | 2022

von Sartaj, A. | Alam, M. | Biswas, L. | +5

5

Solid Self-Nano Emulsifying Nanoplatform Loaded with Tamoxifen and Resveratrol for Treatment of Breast Cancer

enthalten in: Pharmaceutics | 2022

von Shrivastava, N. | Parikh, A. | Dewangan, R. | +6

6

Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronisingin silico,in vitro, andin vivostudies

enthalten in: Journal of drug targeting | 2022

von Sartaj, A. | , A. | Alam, M. | +6

7

Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer : Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization

enthalten in: BioMed research international | 2022

von Sartaj, A. | Annu | Biswas, L. | +4

8

Redox resetting of cisplatin-resistant ovarian cancer cells by cisplatin-encapsulated nanostructured lipid carriers

enthalten in: Nanomedicine (London, England) | 2021

von Mittal, D. | Biswas, L. | Verma, A.

9

Redox resetting of cisplatin-resistant ovarian cancer cells by cisplatin-encapsulated nanostructured lipid carriers

enthalten in: Nanomedicine | 2021

von Mittal, D. | Biswas, L. | Verma, A.

1
[1]